San Diego-based Viking Therapeutics marked itself as a significant competitor within the weight loss drug industry in February after revealing promising info from a mid-stage demo of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when provided being a weekly injection As well as in March the company